Recombinant human activated coagulation factor VII for injection

Coagulation factor VII · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant human activated coagulation factor VII for injection, covering 2022-08-04 to 2022-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor [Phase 3]

See pricing